Regulatory procedures

Systematic management of regulatory procedures for optimized time to market

Regulatory procedures

Asphalion provides reliable support for all types of regulatory procedures and submissions within EU, UK, US and many other regions. We have over 20 years of track record with New Chemical Entities, Biologicals, ATMPs, Orphan Drugs, Generics, OTCs, Herbal Medicines, Homeopathic Medicinal Products, Medical Devices and Food Supplements. We coordinate your submissions, liaise with agencies and solve all potential hurdles, making sure to comply with critical timelines and reducing the time to market. We offer flexible options for support in the submission process, including submission planning, coordination and execution.

Asphalion provides reliable support for all types of regulatory procedures and submissions within EU, UK, US and many other regions. We have over 20 years of track record with New Chemical Entities, Biologicals, ATMPs, Orphan Drugs, Generics, OTCs, Herbal Medicines, Homeopathic Medicinal Products, Medical Devices and Food Supplements. We coordinate your submissions, liaise with agencies and solve all potential hurdles, making sure to comply with critical timelines and reducing the time to market. We offer flexible options for support in the submission process, including submission planning, coordination and execution.

Regulatory procedures Solutions

  • Assessment of regional requirements (Module 1 for new MAA and registration procedures)
  • Support and management of new Marketing Authorization Application submissions to comply with critical timelines
  • Centralized Procedures (CP) in EMA
  • Decentralized Procedures (DCP) and MRPs (Mutual Recognition Procedures) with all European Agencies, including support for National Phases for product information translations, mock-up review, follow-up with advisors until authorization
  • National Procedures, including Fast-Track procedure
  • FDA procedures (IND, NDA, BLA, ANDA)
  • Global roll-out in emerging markets
  • Reliable coordination of local partners for global registration procedures (ROW)
  • Management of labelling
  • Promotional material review
  • Translations

Schedule a free meeting!

Discuss your case with our experts and receive a valuable feedback

Share

Why Asphalion?

Adaptation to specific regulations and dealing with the Health Authorities can be complex. Whether you are working towards a FDA, EMA or any other regulatory submission, Asphalion can provide its expertise and support for a successful registration process.

Having participated in 18 Centralized Procedures, many DCPs and MRPs involving all European Agencies, more than 30 FDA projects and global roll-outs in emerging markets, our experience keeps growing every day.

We also have extensive experience with the management of translations for regulatory submissions processes, especially for Centralized Procedures (from pre-opinion, until linguistic review and opinion by agencies), in which time and accuracy are critical. We can provide support in managing all required activities and processes where you need expert guidance.​

Main benefits

  • Specialized expertise in Regulatory submissions
  • Global procedure management
  • Reduce time to market
Carme Ulla - Asphalion
Carme Ulla
Regulatory Affairs Director
“Our expertise will anticipate any issues or challenges that could arise and will ensure you are prepared to overcome them”

Related Resources

Access consortium

Access Consortium

The Access consortium is a medium-sized coalition of regulatory authorities from Australia, Canada, Singapore, Switzerland and the UK that work together to promote greater regulatory collaboration and alignment of regulatory requirements.

Business Case: eSubmission NDA

Business Case eSubmission NDA

In this business case about an Asphalion eSubmission NDA, a Swiss Pharmaceutical company needed assistance with an initial complete NDA application, including datasets and SPL.

Marketing Authorization Expansion in Europe

Marketing Authorization Expansion in Europe

A case study about Marketing Authorization Expansion in Europe. A small European
Pharmaceutical company with
local activity in its country, with a
growth strategy aiming to
expand to international
markets but lacking experience
and capability in managing
complex EU procedures.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Related News & Events

EVENT | 20th Biosimilar Medicines Conference by MFE

During these two interactive days, actors of the healthcare community alongside world experts in biosimilar medicines will gather and debate the evolving biosimilar medicines landscape and emerging trends. Discussion will focus on sharing good practices and setting collective aims to achieve the depth, breadth and speed of the use of biosimilar medicines as a lever to untap their transformative value.

BUSINESS CASE | Transparency policy 0070

Have a look at this Business Case where Asphalion provided a leading global pharmaceutical company with full regulatory support for the management of Policy 0070 for a new active substance

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting